Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SpecGx
FDA Approves MORPHINE SULFATE — SpecGx LLC

SpecGx LLC received FDA approval for ANDA076438, marking the launch of generic morphine sulfate (oral) in the U.S. market. This move is expected to in...

Fresenius
FDA Approves VALPROATE SODIUM — Fresenius Kabi USA, LLC

# FDA Approves Fresenius Kabi's Intravenous Valproate Sodium Formulation Fresenius Kabi USA, LLC received FDA approval for its intravenous valproate ...

Genentech,
FDA Approves XOLAIR — Genentech, Inc.

Genentech’s (CHI.HS) FDA approval of its subcutaneous administration of OMALIZUMAB for XOLAIR in June 2003 launched a blockbuster franchise that revol...

Amneal
FDA Approves EPINEPHRINE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Epinephrine Injection Amneal Pharmaceuticals of New York LLC has received FDA approval for its subcutaneous ep...

SpecGx
FDA Approves DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — SpecGx LLC

SpecGx LLC announced on Monday that the FDA has approved its new generic drug application (ANDA076353) for extended-release dextroamphetamine sulfate ...

BARR
FDA Approves Unknown Drug — BARR

The FDA has approved Barr Laboratories' NDA for Zoloft, a widely used antidepressant, marking a potential restocking opportunity for the company amids...

Novartis
FDA Approves GLEEVEC — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals marked a decisive revenue milestone with the FDA approval of the blockbuster oncology agent Gleevec in 2003, a pivotal advanc...

Teva
FDA Approves CLARAVIS — Teva Pharmaceuticals USA, Inc.

TEVA PHARMACEUTICALS USA, INC. received FDA approval on April 11, 2003 for Claravis, a generic version of the acne-treating drug isotretinoin, entitli...

Teva
FDA Approves CLARAVIS — Teva Pharmaceuticals USA, Inc.

In 2003, Teva Pharmaceuticals received FDA approval for the oral isoretinoin ANDA (App #: ANDA076135), accelerating the genericization of Claravis and...

URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.

Uronova Pharmaceuticals announced the FDA approval of Vabrimty, a generic Leuprolide Acetate injection, which positions the company to compete directl...

IMPAX
FDA Approves Unknown Drug — IMPAX LABS

Impax Laboratories received FDA approval on January 29, 2003, for ANDA 076173, a generic submission specifically cited for patent litigation. This cle...

Meridian
FDA Approves IDKIT HP ONE — Meridian Bioscience Israel Ltd

Meridian Bioscience Israel Ltd FDA-approved NDA021314 for the oral administration of IDKIT HP ONE, a diagnostic test integrating citric acid anhydrous...

Apotex
FDA Approves BUTORPHANOL TARTRATE — Apotex Corp.

Pfizer has been denied a ruling on its attempt to block Apotex Corp.'s butorphanol tartrate nasal spray (ANDA075499), just days before the 180-day exc...

Prasco
FDA Approves TERIPARATIDE — Prasco Laboratories

Prasco Laboratories' earlier approval of the synthetic peptide teriparatide establishes a foundational market presence for the osteoporosis treatment,...

Eli
FDA Approves STRATTERA — Eli Lilly and Company

Eli Lilly and Company has announced that the capsule form of its branded attention deficit hyperactivity disorder (ADHD) medication STRATTERA (atomoxe...

Sagent
FDA Approves VALPROATE SODIUM — Sagent Pharmaceuticals

# FDA Approves Sagent Pharmaceuticals' Intravenous Valproate Sodium Formulation Sagent Pharmaceuticals has received FDA approval for its intravenous ...

USAntibiotics,
FDA Approves AMOXICILLIN AND CLAVULANATE POTASSIUM — USAntibiotics, LLC

USAntibiotics, LLC announced on Tuesday that the FDA has granted approval for AMOXICILLIN AND CLAVULANATE POTASSIUM, oral dosage form NDA050785, with ...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC

SUN PHARM INDS INC announced today the receipt of FDA approval for the competition-friendly ANDA040446. This regulatory win is likely to bolster the c...

URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.

Uronova Pharmaceuticals announced the FDA approval of VABRINTY (Leuprolide Acetate) Subcutaneous for Autoinjector, continuing the company’s strategy o...

PLIVA
FDA Approves Unknown Drug — PLIVA

PLIVA announced the FDA approval of its ANDA for N/A, signifying a significant step toward establishing a competitive presence in the N/A market and b...